Active Ingredient: Quetiapine
Bipolar disorder: Acute treatment of manic (both immediate release and extended release [ER]) or mixed (ER only) episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex; maintenance treatment of bipolar I disorder, as an adjunct to lithium or divalproex; acute treatment of depressive episodes associated with bipolar disorder
Major depressive disorder (ER only): Adjunctive therapy to antidepressants for the treatment of major depressive disorder.
Schizophrenia: Treatment of schizophrenia.